Table 2.
Cancer-related disease factors predicting 12-week smoking cessation outcomes.
| Variable (referent) | Medication adherence | Counseling adherence | Abstinence | |||
|---|---|---|---|---|---|---|
|
| ||||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Sex (female) | 1.05 (0.48-2.29) | .901 | 0.95 (0.41-2.22) | .912 | 0.70 (0.28-1.75) | .447 |
| Race/ethnicity (minority) | 0.98 (0.43-2.22) | .954 | 0.78 (0.31-1.95) | .595 | 2.85 (1.05-7.73) | .040 |
| Age, 1 year | 1.02 (0.98-1.07) | .356 | 0.98 (0.94-1.03) | .490 | 1.04 (0.99-1.10) | .121 |
| Education (≤ high school degree) | 1.37 (0.55-3.37) | .499 | 0.83 (0.30-2.27) | .720 | 0.52 (0.18-1.52) | .232 |
| Employment status (unemployed/retired) |
0.65 (0.29-1.46) | .300 | 0.84 (0.35-2.00) | .686 | 0.73 (0.29-1.85) | .504 |
| Nicotine dependence, FTND score | 0.98 (0.82-1.18) | .828 | 0.92 (0.75-1.12) | .408 | 0.76 (0.60-0.95) | .016 |
| Medication adherence (nonadherent) |
― | ― | ― | ― | 4.58 (1.66-12.68) | .003 |
| Counseling adherence (nonadherent) |
― | ― | ― | ― | 4.53 (1.07-19.20) | .040 |
| Tumor site (not tobacco-related) |
1.25 (0.50-3.11) | .629 | 1.05 (0.38-2.86) | .929 | 1.99 (0.69-5.74) | .205 |
| Cancer treatment (no current treatment) |
1.53 (0.72-3.23) | .268 | 1.16 (0.52-2.60) | .718 | 1.14 (0.47-2.75) | .775 |
| Time since diagnosis, 30 days | 1.00 (0.98-1.02) | .933 | 0.99 (0.97-1.01) | .393 | 1.00 (0.98-1.03) | .743 |
| Health-related quality of life, SF-12 score | 1.08 (1.01-1.16) | .019 | 1.07 (0.99-1.14) | .080 | 1.06 (0.98-1.15) | .176 |
Bold indicates significance at p<.05. Abbreviations: OR, odds ratio. CI, confidence interval. FTND, Fagerström Test of Nicotine Dependence. SF-12, 12-item Short Form Health Survey.